Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial by Wolf, Jürgen, MD, Hochmair, Maximilian, MD, Han, Ji-Youn, MD PhD, Reguart, Noemi, MD PhD, Souquet, Pierre-Jean, MD, Smit, Egbert F, MD PhD, Orlov, Sergey V, MD PhD, Vansteenkiste, Johan, MD PhD, Nishio, Makoto, MD PhD, de Jonge, Maja, MD PhD, Akerley, Wallace, MD, Garon, Edward B, MD, Groen, Harry J M, MD PhD, Tan, Daniel S W, MD PhD, Seto, Takashi, MD, Frampton, Garrett M, PhD, Robeva, Anna, MS, Carbini, Mariana, MD, Le Mouhaer, Sylvie, MSc, Yovine, Alejandro, MD, Boran, Aislyn, PhD, Bossen, Claudia, PhD, Yang, Yiqun, PhD, Ji, Lexiang, PhD, Fairchild, Lauren, PhD, Heist, Rebecca S, MD

Get full text